Answers are grounded in this paper and cite their sources.
Purpose Simultaneous cholecystectomy (sCHE) is frequently performed during liver resection for metastatic disease for technical or prophylactic reasons, but its impact on postoperative morbidity remains unclear. Methods This retrospective single-center study included 472 patients undergoing liver resection for metastatic disease between 2007 and 2023. Patients were stratified by sCHE status. Postoperative complications were assessed using the Clavien-Dindo classification, with subgroup analyses according to minor or major liver resection. Results Baseline characteristics were comparable between groups, although patients undergoing sCHE had a higher metastatic burden and more frequently received preoperative liver-directed therapies. Postoperative complications occurred more often after sCHE in the overall cohort (55% vs. 45%, p = 0.039), particularly after minor liver resection (56% vs. 39%, p = 0.003). This difference was mainly driven by low-grade Clavien-Dindo complications (47% vs. 26%, p < 0.001), whereas major complications remained comparable ( p = 0.410). No significant difference in postoperative morbidity was observed after major liver resection (57% vs. 70%, p = 0.292). In multivariable analysis, sCHE was not independently associated with postoperative morbidity, while operative duration remained a significant predictor of complications. Conclusion The present findings do not provide evidence supporting routine prophylactic cholecystectomy during liver resection for metastatic disease in the absence of a clear clinical or surgical indication. Increased morbidity observed after minor liver resection was predominantly driven by low-grade complications. The association was not confirmed after multivariable adjustment, potentially reflecting procedural complexity.
No takes yet. Share an insight, caveat, or question.
Seyfried et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: